Skip to search formSkip to main contentSkip to account menu

2-methyl-4-amino-6-oxypyrimidine

Known as: 2-methyl-4-amino-6-hydroxypyrimidine, MAOP, Me-A-oxypyrimidine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
As a companion to the ElectroMagnetic-Power-based Characteristic Mode Theory (EMP-CMT) for PEC systems (PEC-EMP-CMT) and the EMP… 
2016
2016
Many-objective optimization problems (MaOPs), in which the number of objectives is greater than three, are common in various… 
2015
2015
Knowing the values of the Remaining Strength Factor – RSF constitutes a mostly useful tool for the application of the proactive… 
Review
2011
Review
2011
With an overall objective for broad and confident integrity management of the PetroChina Pipeline Company's pipeline network, we… 
2010
2010
V diplomski nalogi smo sestavili model racunalniskega programa, ki je primeren za obcine in raziskali primernost racunalniskega… 
Review
2008
Review
2008
  • Yu Li
  • 2008
  • Corpus ID: 76422509
Objective: To evaluate the therapeutic effectiveness of MAOP regimen on initial treatment for adult acute lymphoblastic leukemia… 
2005
2005
Invention relates to compounds of formula (I), wherein A, R 1 , R 2 , R 3 and R 4 as defined in the description, the present… 
1997
1997
The effect of the immunomodulator 2-methyl-4-amino-6-oxypyrimidine (MAOP)on delayed hypersensitivity was studied in experiments… 
1979
1979
The effect of prodigiozan and pyrimidine derivatives, such as methyluracyl, oxymetacyl and 2-methyl-4-amino-6-hydroxypyrimidine…